RE: Fundamentals remain robust6 Mar 2022 17:15
BB It isn’t disinformation at all, it’s just my observations. All I’ve said that is possibly controversial is that we have next to nothing to sell of any substance - what exactly is disinformation there?
14% of 2021 income was non covid, so 13-14m. We’ve not been told of anything new other than that some stuff will be coming in q4. Most things are delayed so why wouldn’t this be?
We couldn’t even meet our 2021 projection even though the final 2 months of 2021 saw the biggest wave of covid since it started. So the prudent approach is to expect that the reduction in covid income will be far more than the 50% quoted. The market agrees and may even see it as 70-80% (purely speculating here) so at 75% reduction we see circa £24m income from covid and 10-15 non covid so 34-39m total. Ebitda of 37% so 12.6-14.4m. Hardly inspiring, is it?
Again, not information or disinformation but just a very prudent estimate based on figures given to us by the company.
So, please, do tell me what disinformation I’m spreading. Notice you don’t call out those (some self labelled short term traders) who are adamant it is well underpriced.